Gene expression profiling has been at the forefront to advance precision/personalized medicine for multiple diseases. Gene Expression studies in large cohorts help researches to develop signatures for companion assays, patient stratification and therapeutic decisions.
Importance of gene signatures have been demonstrated in multiple therapeutic and diagnostic decisions especially in the case of cancer, organ transplantation, auto-immune diseases, psoriasis and much more.
Our targeted gene expression solutions for translational research relies on nanostring's probe based chemistry- nCounter® which unlike traditional methods, doesn't involve cDNA conversion, amplification or library preparation and works with wide array of sample types including fresh frozen, FFPE, cells, serum, plasma and biological fluids including exosomes.
Theracues offers end to end support from nucleic acid extraction to advanced data analysis with biological insights data from nCounter® assays within 1-3 weeks.
* Depending on sample size and complexity of the project time period may vary, most reports are sent within 3 weeks from the date of sample receival.